Real World Date (RWD) Quality considerations for regulatory purposes

3.45pm – 4pm GMT, 6 November 2024 ‐ 15 mins

Presentation

Session Three: Data, digital technologies and real-world evidence

Session Chair: Kathy Williams, Head of Global Regulatory Policy and Intelligence, AstraZeneca, and Vice-Chair, BIA Regulatory Affairs Advisory Committee